MedTrace Logo

The Effect of Nicotinamide on the Clinical Outcome of Rheumatoid Arthritis Patients

NCT06640309 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2024-10-16

No results posted yet for this study

Summary

A randomized controlled interventional study to evaluate the efficacy and safety of nicotinamide supplementation in rheumatoid arthritis patients receiving conventional synthetic disease modifying anti-rheumatic drugs.

Conditions

Interventions

DRUG

Nicotinamide Tablet

Nicotinamide is anti-inflammatory and antioxidant.

DRUG

conventional synthetic antirheumatic drugs

methotrexate- leflunomide- sulfasalazine- hydroxychloroquine

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Lamia El wakeel, Professor · Professor and head of department of Clinical Pharmacy at Faculty of Pharmacy Ain Shams University

  • May Ahmed, Asst. professor · Assistant professor of Clinical Pharmacy, Ain Shams University-Faculty of Pharmacy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-02
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06640309 on ClinicalTrials.gov